Thank you to our speakers, sponsors, and delegates who joined us in Boston for the summit! If you are interested in future events within our Precision Oncology portfolio, please get in touch at info@hansonwade.com
What Attendees Experienced in 2026
Radioligand therapy is scaling faster than the infrastructure built to support it. As late stage programs accelerate toward commercialization, pressure on isotope supply, GMP manufacturing, automation, logistics, and clinical site readiness is reaching a breaking point.
The organizations that solve these operational bottlenecks first will define the next decade of radiopharmaceutical medicine.
The 4th TRP Supply Chain & Manufacturing Summit was the only industry-dedicated meeting uniting the full radiopharmaceutical supply chain from isotope production and generator capacity through to synthesis, QC, fill finish, distribution, and last mile patient delivery.
Across three focused days, attendees heard directly from leading biopharma teams on how they are securing isotope supply, scaling manufacturing systems, and building resilient, end to end operations ready for commercial demand. Including deep dive case studies, technical discussions, and candid insights not available anywhere else.
Designed exclusively for biopharma, this intimate forum brought together 60+ senior leaders across supply chain, CMC, manufacturing, quality, and logistics ensuring every conversation is relevant, practical, and immediately actionable.
Event Highlights
Secure Reliable Isotope Supply Before Scarcity Impacts Clinical Timelines
Discovered how leading organizations are evaluating production pathways, diversifying sourcing strategies, and building long-term resilience plans to reduce dependency on fragile supply networks.
With insights from:
Learn How Industry Leaders Are Preparing for Geopolitical Disruption & Global Supply Chain Risk
Explored practical approaches to manufacturing site selection, partnership strategy, and supply chain design that can withstand evolving geopolitical pressures, trade restrictions, and cross-border complexity.
With insights from:
Bridge the Gap Between Early Development & Commercial-Scale Manufacturing
Heard how organizations are preparing manufacturing operations, infrastructure, and workforce capabilities for Phase II/III expansion while maintaining product quality and operational flexibility.
With insights from:
Re-Evaluate the Build vs Buy Question Before Your Manufacturing Strategy Is Locked In
Interactive discussions exploring when in-house manufacturing delivers competitive advantage, where CDMO partnerships create greater flexibility, and how hybrid models are emerging across the industry.
With insights from:
Explore What It Really Takes to Close the Loop Between Manufacturing & Patient Delivery
Why manufacturing progress alone will not solve radiopharmaceutical access challenges and discover strategies to better align clinical operations, logistics, site readiness, and patient administration.
With insights from:
Address the Workforce Challenges Threatening Future Manufacturing Capacity
How industry leaders are tackling talent shortages, broadening workforce models, and developing the skills required to support the next generation of radiopharmaceutical manufacturing.
With insights from:
Attending Companies Included